Quantcast
Last updated on April 23, 2014 at 17:08 EDT

Latest Deep brain stimulation Stories

2013-02-13 17:42:01

Large study shows continued improvement with longer follow-up, reports Neurosurgery For many patients with difficult-to-treat neuropathic pain, deep brain stimulation (DBS) can lead to long-term improvement in pain scores and other outcomes, according to a study in the February issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. About two-thirds of eligible...

2013-02-13 14:50:20

Two patients freed from severe to disabling effects of dystonia through deep brain stimulation therapy continued to have symptom relief for months after their devices accidentally were fully or partly turned off, according to a report published online Feb. 11 in the journal Movement Disorders. "Current thought is that symptoms will worsen within hours or days of device shut-off, but these two young men continued to have clinical benefit despite interruption of DBS therapy for several...

2013-02-05 12:27:47

LOS ANGELES, Feb. 5, 2013 /PRNewswire/ -- One of the first known surgeons to offer Deep Brain Stimulation (DBS) as an outpatient treatment, Christopher Duma, MD, FACS, is bringing a new option and hope to the estimated 60,000 Americans diagnosed with Parkinson's Disease every year. The pioneering brain surgeon, who has successfully controlled tremors in thousands of movement disorder patients, is now performing his minimally invasive implantations at DISC Surgery Center at Newport Beach....

2013-01-28 23:01:06

[193 Pages Report] Neuromodulation devices market report categorizes the global market of Spinal Cord Stimulation, Vagus Nerve Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation & Trans-cranial Magnetic Stimulation by procedure, technology, and application. (PRWEB) January 28, 2013 The “Neuromodulation Market — [Spinal Cord Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation & Trans-cranial...

2012-09-27 22:21:42

NATICK, Mass., Sept. 28, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) received CE Mark approval for use of its Vercise(TM) Deep Brain Stimulation (DBS) System for the treatment of Parkinson's disease. The Vercise DBS System is the first and only commercially available DBS system to incorporate multiple independent current control, which is designed to selectively stimulate targeted areas in the brain. This system is an innovative technology that is designed to provide...

2012-09-24 22:20:50

LOS ANGELES, Sept. 25, 2012 /PRNewswire/ -- NeuroSigma, Inc., a Los Angeles-based medical device company, announced today that its Monarch(TM) eTNS(TM) system for the adjunctive treatment of epilepsy and depression will make its debut at the 10th European Congress on Epileptology, which takes place in London, England from September 30 to October 4, 2012. "This conference represents an outstanding opportunity to put the Monarch in the hands of many healthcare professionals who will...

2012-09-04 22:21:18

LOS ANGELES, Sept. 5, 2012 /PRNewswire/ -- NeuroSigma, Inc., a Los Angeles-based medical device company, announced today that it received CE Certification for its external Trigeminal Nerve Stimulation (eTNS(TM)) system, called the Monarch(TM), for the adjunctive treatment of epilepsy and major depressive disorder, for adults and children 9 years and older. NeuroSigma's approval was supported by years of safety and compelling efficacy data generated in clinical trials conducted at the...

2012-07-16 11:04:08

Novel system will help treat diseases like Parkinson's, Tourette's and depression Mayo Clinic researchers have found a novel way to monitor real-time chemical changes in the brains of patients undergoing deep brain stimulation (DBS). The groundbreaking insight will help physicians more effectively use DBS to treat brain disorders such as Parkinson's disease, depression and Tourette syndrome. The findings are published in the journal Mayo Clinic Proceedings. Journalists: For multimedia...

2012-07-16 06:29:33

(Ivanhoe Newswire) — Parkinson's, Tourette Syndrome and Depression.  They are a debilitating disease and they also share something else in common, a surplus or deficiency of neurochemicals in the brain. Now, researchers have found a novel way to monitor real-time chemical changes in the brains of patients undergoing deep brain stimulation. The research conducted by the Mayo Clinic will help physicians more effectively use DBS to treat brain disorders. "We can learn what...

2012-07-02 02:23:31

LOS ANGELES, July 2, 2012 /PRNewswire/ -- Today NeuroSigma, Inc., a Los Angeles-based medical device company, announced that it received ISO 13485: 2003 certification, indicating that it operates a Quality Management System for the design, manufacturing and distribution of its external Trigeminal Nerve Stimulation (eTNS(TM)) system for the treatment of neurological and neuropsychiatric disorders. This certification is an important first step in a two-step process towards CE Mark approval in...